iRapid
What's iRapid APK?
iRapid is a app for Android, It's developed by iSchemaView author.
First released on google play in 5 years ago and latest version released in 5 years ago.
This app has 0 download times on Google play
This product is an app in Medical category. More infomartion of iRapid on google play
iRAPID APP FEATURES:
- Centralized Patient Results
- Custom PHI Configurability
- Custom App Notifications
- Biometric Login (FaceID & Fingerprint)
- Multifactor Authentication
*iRAPID Login required for use
iSchemaView is the world-wide leader in advanced imaging for stroke. Installed in over 1,000 stroke centers, iSchemaView’s RAPID (automated CTP, MRI, CTA and ASPECTS), with enhanced AI framework, is the most advanced stroke imaging platform.
In clinical trials, RAPID has been shown to aid in the selection of patients for therapy in early and late-window stroke trials, including SWIFT PRIME, EXTEND IA, DAWN, DEFUSE 3 and EXTEND. In addition to achieving the best clinical outcomes and largest treatment effects ever obtained, these landmark studies led to new American Heart Association and American Stroke Association guidelines and have dramatically altered the management of acute stroke around the world.
- Centralized Patient Results
- Custom PHI Configurability
- Custom App Notifications
- Biometric Login (FaceID & Fingerprint)
- Multifactor Authentication
*iRAPID Login required for use
iSchemaView is the world-wide leader in advanced imaging for stroke. Installed in over 1,000 stroke centers, iSchemaView’s RAPID (automated CTP, MRI, CTA and ASPECTS), with enhanced AI framework, is the most advanced stroke imaging platform.
In clinical trials, RAPID has been shown to aid in the selection of patients for therapy in early and late-window stroke trials, including SWIFT PRIME, EXTEND IA, DAWN, DEFUSE 3 and EXTEND. In addition to achieving the best clinical outcomes and largest treatment effects ever obtained, these landmark studies led to new American Heart Association and American Stroke Association guidelines and have dramatically altered the management of acute stroke around the world.
